ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
49 announcements
Mphasis Ltd promoters released existing share pledges following a US$550 million refinancing. New encumbrances were created for the ₹5275.60 Crore 2026 Facility without changing shareholding.
Mphasis Limited has allotted 39,193 equity shares following the exercise of options under its ESOP 2016 and RSU Plan 2021. The allotment was approved by the ESOP Compensation Committee on May 7, 2026. This routine issuance reflects the conversion of employee stock-based incentives into equity.
Mphasis Limited received a penalty order of ₹0.19 Crore from the Karnataka GST authorities. The penalty relates to late reversal of input tax credits and SEZ endorsement issues. The company states there is no material impact on its financial or operational activities.
Mphasis Ltd reported a ₹0.01 Crore fine imposed by NSE and BSE for non-compliance with board composition norms regarding independent directors. The company has submitted a waiver application to the exchanges. All other secretarial standards and SEBI regulations were found to be in compliance for FY2026.
Mphasis Q4 FY26 revenue reached $463 Mn, growing 7.1% YoY CC. The company achieved record annual net new TCV of $2.12 Bn, driven by an AI-first strategy and NeoIP platform adoption.
Mphasis reports strong FY26 performance led by high-growth AI-first strategies and BFSI recovery, despite logistical headwinds.
Mphasis FY26 revenue grew 6.7% YoY to $1.8Bn with a 15.3% operating margin. Strategy focuses on AI-led engineering through the NeoIP suite and TAP acquisition.
Mphasis Ltd reported revenue from operations of ₹4,243 Cr (+14.4% YoY) and net profit of ₹509.6 Cr (+14.1% YoY) for Q4 FY26.
Mphasis Ltd reported consolidated revenue of ₹15,879.65 Crore for FY26, a growth of 11.6% YoY. The Board recommended a final dividend of ₹62 per share and approved the 5-year re-appointment of Mr. Nitin Rakesh as CEO and MD. The company also announced the re-appointment of Ms. Maureen Anne Erasmus as an Independent Director.
Mphasis Limited has appointed Mr. Richard Miller as Executive Vice President and Global Head of Insurance Business, effective April 27, 2026. Miller brings over 35 years of experience from Accenture and REMVENTION.AI to lead the company's global insurance strategy and AI-led transformation initiatives for financial services clients.
Mphasis Limited, through its subsidiary, is acquiring Canadian AI and data science firm TAP for up to CAD 30 million (approx. ₹204.0 Crore). The acquisition includes an upfront CAD 10 million payment and reinforces Mphasis’ AI-led platform capabilities while expanding its retail and CPG portfolio. The transaction is expected to close immediately.
Mphasis Limited has appointed Ms. Rogayeh Tabrizi as Executive Vice President – Consumer Packaged Goods (CPG) and Head of Decision AI, effective April 21, 2026. Dr. Tabrizi, an expert in AI and behavioral economics, previously founded Theory and Practice Business Intelligence Inc. This senior appointment aims to strengthen the company's data-driven decision intelligence capabilities.
Mphasis Limited has appointed Ms. Rogayeh Tabrizi as Executive Vice President – CPG and Head of Decision AI, effective April 21, 2026. Ms. Tabrizi brings over 20 years of experience in data-driven insights and behavioral economics, previously serving as CEO of TAP and contributing to CERN's ATLAS Detector project.
Mphasis acquired 100% of Theory and Practice Business Intelligence Inc. (TAP) for up to ₹204.00 Crore (CAD 30 million). The acquisition strengthens Mphasis' decision intelligence capabilities and Retail/CPG portfolio. The deal includes a CAD 10 million upfront payment and CAD 20 million in performance-linked consideration.
MphasiS Limited has scheduled a Board Meeting on April 29, 2026, to approve audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The board will also consider recommending a final dividend. Trading window closure commenced on March 23, 2026.
Mphasis Ltd reported net profit of ₹442 Cr (+3.3% YoY) for Q3 FY26.
Mphasis Limited granted 5,000 stock options to employees under its ESOP 2016 Plan. The options have an exercise price of ₹2,140 each, a 5-year vesting period, and an exercise period of 60 months from vesting.
Mphasis Limited allotted 2,61,697 equity shares during Q4 FY2026 pursuant to its ESOP 2016 Scheme and RSU grants. This allotment increased the company's listed capital to 19,08,19,570 shares. The filing was part of a routine Reconciliation of Share Capital Audit Report submitted under SEBI regulations.
Mphasis delivered steady Q3 results with record TCV doubling YoY. While the AI-led pipeline is robust, rising debt and DSO suggest underlying working capital friction despite stable margins.